TRAW — Traws Pharma, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1130598 ·
Last close
$0.84
Market Cap
$12.69M
52W High
$3.23
52W Low
$0.64
ADV30
1,654,001
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -6,946,000 | -7,107,000 | 8,156,000 | 3,133,000 | 13,467,000 |
| Dec 2025 | 0 | — | -7,368,000 | -7,443,000 | 10,617,000 | 3,820,000 | 11,246,000 |
| Sep 2025 | 0 | — | -4,055,000 | -3,962,000 | 12,443,000 | 6,420,000 | 7,898,000 |
| Jun 2025 | 2,733,000 | — | -1,249,000 | -915,000 | 15,622,000 | 13,081,000 | 7,360,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,324,000
Investing CF
$-2,585,000
Financing CF
$5,088,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.11
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-647,091,000
Inventory
—
Receivables
$1,687,000
ST Investments
—
EBIT TTM
$-19,618,000
Pretax Income TTM
$-19,427,000
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,733,000
EBITDA
$-19,514,000
Free Cash Flow
$-10,347,250
Enterprise Value
$9,555,685
Total Cash
$3,133,000
Total Debt
$0
Shares Out
15,150,669
Trailing EPS
$-1.87
Book Value
$-0.07
ROE
-5639.2%
ROA
-90.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,790,000 | -17,875,000 | 9,170,000 | 10,617,000 | 11,246,000 | — | -18,185,000 |
| Dec 2024 | 226,000 | -24,910,000 | -166,523,000 | 24,962,000 | 56,592,000 | — | -29,792,000 |
| Dec 2023 | 226,000 | -20,298,000 | -18,948,000 | 22,683,000 | 12,011,000 | — | -17,932,000 |
| Dec 2022 | 226,000 | -19,627,000 | -18,964,000 | 39,372,000 | 11,063,000 | — | -16,294,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.98
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CALC | CalciMedica, Inc. | $12.69M | $0.80 | — |
| BFRG | BullFrog AI Holdings, Inc. | $12.28M | $0.66 | — |
| BFRI | Biofrontera Inc. | $13.19M | $1.03 | — |
| PHIO | Phio Pharmaceuticals Corp. | $12.08M | $1.04 | — |
| APUS | Apimeds Pharmaceuticals US, Inc. | $13.43M | $0.89 | — |
News headlines (Yahoo Finance, 1h cache)
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
2026-06-22 11:00 · Yahoo
SpaceX initiated, Salesforce upgraded: Wall Street's top analyst calls
2026-06-18 13:35 · Yahoo
Traws Pharma Shares Slide After UK Regulator Postpones Influenza Study
2026-06-15 10:26 · Yahoo
Why Did TRAW Stock Slump 28% After Hours?
2026-06-13 00:07 · Yahoo
Traws Pharma Provides Regulatory Update on Influenza Program
2026-06-12 21:30 · Yahoo
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
2026-05-27 12:45 · Yahoo
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
2026-05-15 11:00 · Yahoo
Sector Update: Healthcare Stocks Lower Late Afternoon
2026-05-08 19:58 · Yahoo
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
2026-05-08 11:30 · Yahoo
Traws Pharma, Inc. (TRAW) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
2026-04-20 13:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.